Steven Cohen Pharvaris N.V. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Pharvaris N.V. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 37,612 shares of PHVS stock, worth $879,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,612
Previous 52,574
28.46%
Holding current value
$879,744
Previous $825,000
19.88%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$176 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$103 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$100 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$85.5 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$77.3 Million17.44% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $790M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...